Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpointYves Agid, Eduardo Tolosa, Eric Ahlskog et al.|Movement Disorders|1999Cited by 88
A Statement of the <scp>MDS</scp> on Biological Definition, Staging, and Classification of Parkinson's DiseaseFrancisco Cardoso, Claudia Trenkwalder, Bastiaan R. Bloem et al.|Movement Disorders|2023Cited by 83
Selective increase of Nurr1 mRNA expression in mesencephalic dopaminergic neurons of D2 dopamine receptor-deficient miceKuei Y. Tseng, Rita Raisman‐Vozari, Marcelo Rubinstein et al.|Molecular Brain Research|2000Cited by 21